Top of this page
Skip navigation, go straight to the content
FAQs
Answers to our investors' frequently asked questions:
What are UCB main areas of activities?
The company focuses on severe diseases in the fields of the central nervous system (including epilepsy), inflammation (including allergy) and oncology.
Your questions our answers
- When was UCB founded?
- What are UCB main areas of activities?
- How many people does the new UCB employ?
- What are the group key figures?
- What are UCB's topselling products during the first half 2007?
- On which accounting standards are the consolidated financial statements of the UCB group based?
- How is the fiscal year defined?
- Does UCB reports quarterly?
- When will the next shareholders' meeting take place?
- Amount and date of the current dividend?
- What are the major shareholders of UCB?
- How many UCB shares are outstanding?
- Does UCB have ADR (American Depositary Receipt)?
- What is UCB's position with respect to the Corporate Governance principles?
- How can I order UCB annual reports?
- As a former Celltech shareholder, how can I return my shares to UCB?
- As a Schwarz Pharma shareholder, how and when can I return my shares to UCB SP GmbH?
